Characterization of antibody response to hepatitis C virus protein E2 and significance of hypervariable region 1-specific antibodies in viral neutralization

Archives of Virology

Volumn 142, Issue 3, 1997, Pages 523-534

  Zibert, A ^a,c   Dudziak, P ^a   Schreier, E ^b   Roggendorf, M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c Institute of Virology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E2, HEPATITIS C VIRUS; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; BLOOD; CELL LINE; DRUG CONTAMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SERODIAGNOSIS; VIROLOGY;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; BASE SEQUENCE; CELL LINE; DRUG CONTAMINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PRECIPITIN TESTS; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS;

EID: 0030895466     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050098     Document Type: Article

References (36)

1. Alter HJ (1989) The chronic consequences of non-A, non-B hepatitis. Curr Persp. Hepatol 2: 83-97
2. Bertolini L, Iacovacci S, Ponzetto A, Gorini G, Battaglia M, Carloni G (1993) The human bone-marrow-derived B-cell line CE, susceptible to hepatitis C virus infection. Res Virol 144: 281-285
3. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo QL, Shuster JR, Kuo G, Bonino F, Houghton M, Abrighani S (1993) T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104: 580-587
4. Chien DY, Choo QL, Ralston R, Spaete R, Tong M, Houghton M, Kuo G (1993) Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342: 435-436
5. Choo Q-L, Kuo G, Ralston R, Weiner AJ, Chien D, van Nest G, Han J, Berger K, Thudium K, Kuo C, Kansopon J, McFarland J, Tabrizi A, Ching K, Moss B, Cummuns LB, Houghton M (1994) Vaccination of chimpanzees against infection by hepatitis C virus. Proc Natl Acad Sci USA 91: 1294-1298
6. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B hepatitis genome. Science 244: 359-362
7. Dienstag JL (1983) Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85: 439-462
8. Dittmann S, Roggendorf M, Dürkop J, Wiese M, Lorbeer B, Deinhardt F (1991) Long-term persistence of hepatitis C virus antibodies in a single source outbreak, J Hepatol 13: 323-327
9. Driesel G, Wirth D, Stark K, Baumgarten R, Sucker U, Schreier E (1994) Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region. Arch Virol 139: 379-388
10. Erickson AL, Houghton M, Choo QL, Weiner AJ, Ralston R, Muchmore E, Walker CM (1993) Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol 151:4189-4199
11. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, Purcell RH (1994) Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization Proc Natl Acad Sci USA 91: 7792-7796
12. Fox GN, Parry G, Barnett PV, McGinn B, Rowlands DJ, Brown F (1988) The cell attachment site of foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol 70: 625-637
13. Guan KL, Dixon JE (1991) Eukaryotic proteins expressed in E. coli: an improved thrombin cleavage site and purification method of fusion proteins with glutathione S-transferase gene 192: 262-267
14. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y, Ishikawa T, Takayanagi M, Nagai Y (1993) Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 197: 659-668
15. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K (1991) Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 175: 220-228
16. Höhne M, Schreier E, Roggendorf M (1994) Sequence variability in the envcoding region of hepatitis C virus isolated from patients infected during a single source outbreak. Arch Virol 137: 25-34
17. Javaheria KA, Langlois AJ, McDanal C, Ross KL, Eckler LI, Jellis CL, Profy AT, Rushe JR, Bolognesi DP, Putney SD, Matthews TJ (1989) Principal neutralising domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci USA 86: 6768-6772
18. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K (1991) Genetic organization and diversity of the hepatitis C virus. Proc Natl Acat Sci USA 88: 2451-2455
19. Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, Shimotohno K (1994) Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 68: 4776-4784
20. Kato N, Ootsuyama Y, Tanaka T, Nakagawa M, Nakazawa T, Muraiso K, Ohkoshi S, Hijikata M, Shimotohno K (1992) Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res 22: 107-123
21. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimotohno K (1993) Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 67: 3923-3930
22. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD (1992) Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149: 3339-3344
23. Kumar U, Monjardino J, Thomas HC (1994) Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 106: 1072-1075
24. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W-S, Kuo C, Berger K, Shuster J R, Overby LR, Bradley DW, Houghton M (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362
25. Lanford RE, Sureau C, Jacob JR, White R, Fuerst TR (1994) Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT-PCR. Virology 202: 606-614
26. Miller RH, Purcell RH (1990) Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci USA 87: 2057-2061
27. Nissen E, Höhne M, Schreier E (1993) In vitro replication of hepatitis C virus in a human lymphoid cell line (H9). J Hepatol 20: 437
28. Rümenapf T, Stark R, Meyers G, Thiel H-J (1991) Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J Virol 65: 589-597
29. Schlesinger JJ, Brandriss MW, Cropp CB, Monath TP (1986) Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol 60: 1153-1155
30. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H (1994) Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 68: 1494-1500
31. Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H (1992) Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci USA 89: 5477-5481
32. Shimizu YK, Purcell RH, Yoshikura H (1993) Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proc Natl Acad Sci USA 90: 6037-6041
33. Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanka T, Munekata E, Muchmore EE, Peterson DA, Mishiro S (1993) A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology 195: 297-301
34. Viazov S, Zibert A, Ramakrishnan K, Widell A, Cavicchini A, Schreier E, Roggendorf M (1994) Typing of hepatitis C virus isolates by DNA enzyme immunoassay. J Virol Meth 48: 81-92
35. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M (1992) Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 89: 3468-3472
36. Zhang Y-M, Hayes EP, McCarty TC, Dubois DR, Summers PL, Eckels KE, Chanock RM, Lai C-J (1988) Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. J Virol 62: 3027-3031